Ledger.Open graph →
SEC Form D · filed January 4, 2023

Hoth Therapeutics, Inc

Offering
$10.0M
Sold
$10.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW YORK, NY
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (17)

Graig Springer · New York, NYDirectorDavid Briones · New York, NYExecDavid Sarnoff · New York, NYDirectorRobb Knie · New York, NYExec · DirectorWayne Linsley · New York, NYDirectorJeff Pavell · New York, NYDirectorGarth Ebanks · Grand Cayman, Cayman IslandsDirectorShelley Chu · Waltham, MADirectorSimon Read · Waltham, MADirectorPatrick Trojer · Waltham, MAExecRandall W. Mueller · O'Fallon, MOExec · DirectorJeffery Sarrett · Denver, COExec · DirectorRachid Mallouk · Luxembourg, LuxembourgExecAndre G. Missuc · Luxembourg, LuxembourgDirectorTodd Berning · West Fargo, NDDirectorCarle Stenmark · San Francisco, CADirectorJeff Pavell · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗